Wegovy gets higher-dose approval; Novo Nordisk ka big tilt on obesity meds. Danish pharma giant, backed by Novo Holdings/Foundation.
Several major corporations released their 2025 financial results, showing varied performance. Tui reported stable revenue and growth in cruises and holiday experiences. AstraZeneca and Novo Nordisk faced challenges with sales forecasts amid pricing pressures. Shell and BP experienced profit declines due to falling oil prices, with Shell increasing debt to sustain shareholder payouts. Exxon posted a solid quarter despite lower revenue. The results highlight ongoing industry shifts and economic pressures as 2026 begins.
Recent studies reveal AI chatbots like ChatGPT generate meal plans for teenagers that significantly underestimate calorie and nutrient requirements, risking health issues. Experts warn against relying solely on AI for adolescent nutrition, emphasizing the importance of professional guidance to ensure balanced diets during critical growth periods. This update highlights ongoing concerns about AI's limitations in personalized health advice.